Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer.

Authors

Ephraim S Tang
Philippa H Newell, Integrated Therapies Laboratory, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon.Follow
Ronald F Wolf
Paul Daniel Hansen
Benjamin Cottam, Integrated Therapies Laboratory, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon.
Carmen Ballesteros-Merino, Integrated Therapies Laboratory, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon.Follow
Michael J Gough, Integrated Therapies Laboratory, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon.Follow

Document Type

Article

Publication Date

8-8-2018

Publication Title

JAMA Surg

Clinical Institute

Cancer

Clinical Institute

Digestive Health

Specialty

Oncology

Specialty

Gastroenterology

Specialty

Earle A. Chiles Research Institute

Recommended Citation

Tang, Ephraim S; Newell, Philippa H; Wolf, Ronald F; Hansen, Paul Daniel; Cottam, Benjamin; Ballesteros-Merino, Carmen; and Gough, Michael J, "Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer." (2018). Articles, Abstracts, and Reports. 626.
https://digitalcommons.providence.org/publications/626